Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

GSK 1,451.53 -5.47 (-0.38%)
price chart
GlaxoSmithKline settles healthcare fraud case for $3 billion
WASHINGTON GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S.
GlaxoSmithKline to pay $3billion fine after pleading guilty to healthcare ...  Daily Mail
Glaxo Agrees to Pay $3 Billion in Fraud Settlement  New York Times
GSK clinches deal to buy Human Genome for $3 billion
LONDON/BOSTON GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile pursuit of the U.S.
Glaxo to Pay $3 Billion for Human Genome  Bloomberg
HGS Agrees to $3.6B GSK Buyout; Deal Inked at $14.25 Per Share  BioWorld Online
3 UK Stocks With US-Style Dividends And No Tax Withholding For A Dividend ...
... British multinationals in three diverse sectors that pay American-style quarterly dividends that remain stable with consistent growth from year to year: Royal Dutch Shell PLC Class B (RDS.
British drugmaker to pay $3 billion in fines
The Justice Department said Monday that GlaxoSmithKline PLC will plead guilty to promoting popular antidepressants Paxil and Wellbutrin for unapproved uses.
Glaxo in $3 Billion Settlement  Wall Street Journal
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
Big Pharma is in big trouble – or at least it should be
Something is definitely wrong in their management and monitoring systems. GSK are not able to say that the activities for which they were fined were anything other than deliberate.
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
Two senior executives at GlaxoSmithKline Plc singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies.
What is a defensive stock?
How Pennon Group plc (3.91%) could soon yield more than GlaxoSmithKline plc (5.50%) and Rio Tinto plc (7.40%). Which will double the quickest, Aviva plc, ARM Holdings plc or Anglo American plc?
Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources
Human Genome, which last week agreed to be bought by British drugmaker GlaxoSmithKline Plc for $14.25 per share -- or $3 billion -- said in a filing with regulators last week that the company had received, and rebuffed, a preliminary takeover bid at ...
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test
An experimental treatment for HIV developed by GlaxoSmithKline Plc, Pfizer Inc. and Shionogi & Co. reduced the virus in more people than Gilead Sciences Inc.'s Atripla, suggesting it may supplant the world's best-selling AIDS medicine as the preferred ...